Patent details

Basic Information

Publication number:

EP4324521

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP232199372

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

MIGALASTAT FOR USE IN THE TREATMENT OF FABRY DISEASE IN ERT-NAIVE AND ERT-EXPERIENCED PATIENTS

French Title of Invention:

MIGALASTAT POUR SON UTILISATION DANS LE TRAITEMENT DE LA MALADIE DE FABRY CHEZ DES PATIENTS AYANT SUBI ET N'AYANT JAMAIS SUBI DE THÉRAPIE ERT

German Title of Invention:

MIGALASTAT ZUR VERWENDUNG IN DER BEHANDLUNG VON MORBUS FABRY BEI ERT-NAIVEN UND ERT-ERFAHRENEN PATIENTEN

SPC Number:

Dates

Filing date:

19/07/2017

Grant date:

08/04/2026

EP Publication Date:

21/02/2024

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/04/2026

EP B1 Publication Date:

08/04/2026

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

19/07/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

01/04/2026

 

 

Name:

Amicus Therapeutics, Inc.

Address:

3675 Market Street, Philadelphia, PA 19104, United States (US)

Inventor

Name:

Castelli, Jeff

Address:

United States (US)

Priority

Priority Number:

201615213920

Priority Date:

19/07/2016

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/445; A61P 9/00; A61P 3/00; A61P 13/12;

Publication

European Patent Bulletin

Issue number:

202615

Publication date:

08/04/2026

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

31/07/2026

Annual Fee Number:

10

Annual Fee Amount:

131 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages